Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-09-13, Stock:JNJ, The news for the past five days is as follows:
2019-09-06: NEWS1: Pharma Stock Roundup: AGN's Opioid Settlement, Line Extension Nod in EU for MRK, JNJ Drugs.NEWS2: Health Care Sector Update for 09/06/2019: NTGN, MYOV, VIVE, JNJ, PFE, ABT, MRK, AMGN.NEWS3: Health Care Sector Update for 09/06/2019: NTGN, MYOV, VIVE, JNJ, PFE, ABT, MRK, AMGN.NEWS4: Mallinckrodt’s suffers record plunge after report bankruptcy is being considered.NEWS5: Mallinckrodt Mulls Bankruptcy Ahead of Major Opioid Litigation.NEWS6: How Will Johnson & Johnson's Opioid Case Ruling Impact Big Pharma Stocks?.NEWS7: How Will Johnson & Johnson's Opioid Case Ruling Impact Big Pharma Stocks?.
2019-09-09: NEWS1: Mallinckrodt (MNK) to Resolve Opioid Cases with Ohio Counties.NEWS2: The Zacks Analyst Blog Highlights: Allergan, Merck, Roche, J&J and Bristol-Myers.NEWS3: Health Care Sector Update for 09/09/2019: ACAD, AXNX, AMGN, JNJ, PFE, ABT, MRK.NEWS4: Health Care Sector Update for 09/09/2019: ACAD, AXNX, AMGN, JNJ, PFE, ABT, MRK.NEWS5: An Intrinsic Calculation For Johnson & Johnson (NYSE:JNJ) Suggests It's 43% Undervalued.NEWS6: Here's Why Teva Pharmaceuticals Dropped 13% in August.NEWS7: Here's Why Teva Pharmaceuticals Dropped 13% in August.NEWS8: Here's Why Arrowhead Pharmaceuticals Rose 17.6% in August.NEWS9: Here's Why Arrowhead Pharmaceuticals Rose 17.6% in August.
2019-09-10: NEWS1: The Zacks Analyst Blog Highlights: Allergan, Merck, Roche, J&J and Bristol-Myers.NEWS2: The Zacks Analyst Blog Highlights: Allergan, Merck, Roche, J&J and Bristol-Myers.NEWS3: Theravance Announces Positive Early Data on JAK Inhibitor.NEWS4: 10 Healthcare Stocks to Buy Despite the Headlines.NEWS5: Health Care Sector Update for 09/10/2019: CANF, MNK, MESO, JNJ, PFE, MRK, ABT, AMGN.NEWS6: Health Care Sector Update for 09/10/2019: CANF, MNK, MESO, JNJ, PFE, MRK, ABT, AMGN.NEWS7: What To Make of Roche's Drugs With $21 Billion In Sales Nearing Patent Expiry?.NEWS8: What To Make of Roche's Drugs With $21 Billion In Sales Nearing Patent Expiry?.NEWS9: Bristol-Myers Squibb's Revenues: How Does Bristol-Myers Squibb Make Money?.NEWS10: Bristol-Myers Squibb's Revenues: How Does Bristol-Myers Squibb Make Money?.
2019-09-11: NEWS1: Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know.NEWS2: Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know.NEWS3: Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know.NEWS4: Noteworthy ETF Outflows: IWV, MSFT, AMZN, JNJ.NEWS5: Noteworthy ETF Outflows: IWV, MSFT, AMZN, JNJ.NEWS6: Mallinckrodt to Divest Contract Manufacturing Unit, Stock Up.NEWS7: Lexicon (LXRX) Settles With Sanofi for $260M, Shares Rally.NEWS8: Health Care Sector Update for 09/11/2019: TTOO, LXRX, SNY, TLRY, JNJ, PFE, MRK, ABT, AMGN.NEWS9: Health Care Sector Update for 09/11/2019: TTOO, LXRX, SNY, TLRY, JNJ, PFE, MRK, ABT, AMGN.
2019-09-12: NEWS1: 6 Stocks With Low Price-Sales Ratios.NEWS2: Alabama hospitals file suit against opioid manufacturers and distributors.NEWS3: Rep. McHenry says Trump is publicly saying what everybody privately grumbles about.NEWS4: J&J's Ponesimod Superior to Aubagio in Relapsing MS Patients.NEWS5: J&J's Ponesimod Superior to Aubagio in Relapsing MS Patients.NEWS6: J&J's Ponesimod Superior to Aubagio in Relapsing MS Patients.NEWS7: 9 Best Dividend Stocks to Buy for Every Investor.NEWS8: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 13, 2019.NEWS9: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 13, 2019.

Answer: Rise